July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices offer good battery longevity and MRI compatibility. In addition, the new devices offer Bluetooth technology and a new patient smartphone app for improved remote monitoring, allowing for increased patient/physician engagement and streamlined communications.

Cardiac MRI for four children with clinical diagnosis of acute myocarditis in the setting of COVID-19–related Kawasaki-like symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C). Cardiac MRI of COVID pediatric COVID-19 patients.

July 8, 2020 — Cardiac magnetic resonance imaging (MRI) has been shown to be helpful in evaluating multisystem inflammatory syndrome in children (MIS-C), which presents with Kawasaki disease-like features related to the child's exposure to COVID-19 (SARS-CoV-2).

July 9, 2020 — The Society for Vascular Surgery (SVS) has released a clinical competence statement on training and credentialing for trans-carotid artery revascularization (TCAR) to ensure that patients who are at risk of a stroke receive safe and effective preventative care with this new and promising technology by an experienced and appropriately trained physician

Older Critically Ill COVID-19 Patients May Have Increased Risk of Bradycardia With Lopinavir and Ritonavir.

July 9, 2020 — Older, critically ill patients with COVID-19 (SARS-CoV-2) who received a combination of the antiretroviral medications lopinavir and ritonavir were more often seen to experience bradycardia, a slow heart rate, according to new research published today in Circulation: Arrhythmia and Electrophysiology, an American Heart Association (AHA) journal.[1]

July 9, 2020 – Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System.

July 8, 2020 – Judy W. Hung, M.D., FASE, took the helm as president of the American Society of Echocardiography (ASE) in late June. She has served on the ASE Board of Directors as vice president and president-elect prior to ascending to her one-year presidency. 

July 9, 2020 – The Minneapolis Heart Institute Foundation (MHIF) is conducting additional research on a novel hydrogel that is designed to repair cardiac tissue. In April 2020, the FDA approved an investigational new drug (IND) application to investigate the safety and feasibility of delivering VentriGel via catheter into areas of the heart of patients that cannot be completely revascularized at the time of coronary artery bypass grafting (CABG). 

July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agreement to deliver on the Trusts’ vision to set new standards of excellence for cardiac care in the U.K. and globally. The partnership will combine the latest innovations in technology for integrated cardiovascular solutions. The aim of the partnership is better health outcomes, lower cost of care and an improved experience for patients and staff.

July 7, 2020 – MedAlliance announced enrollment of the first patient in its study of Selution SLR 0.014 drug-eluting balloon (DEB) for the treatment of in-stent restenosis (ISR). This is the first DEB accepted by the FDA for its breakthrough program. The Selution SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to a drug-eluting stent (DES).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now